CRISPR screening synthetic lethal factors with CDK4/6 inhibitors in ER+ breast cancer cells
To explore for targets whose inhibition synthetic lethal with CDK4/6 inhibitors in ER+ breast cancer cells, we screened MCF-7 cells with CRISPR screening.